Introducing a New Biomarker Named R2 *‐ BOLD‐MRI Parameter to Assess Treatment Response in Osteosarcoma
Year: 2021
Type: article
Study design: Observational Study
DOI: 10.1002/jmri.28023
Institutions: Samsung Medical Center, Sungkyunkwan University
Language: English
Topic: MRI in cancer diagnosis
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4200411814